Brief: Heat Biologics- Covid-19 Vaccine Demonstrates Robust T Cell Driven Immune Response To Sars-Cov-2 In Preclinical Studies

Scorpius Holdings

13/08/2020 14:38

Aug 13 (Reuters) - Heat Biologics Inc  HTBX.O :
    * HEAT BIOLOGICS INC - COVID-19 VACCINE DEMONSTRATES ROBUST
T CELL
DRIVEN IMMUNE RESPONSE TO SARS-COV-2 IN PRECLINICAL STUDIES
    * HEAT BIOLOGICS INC - NOTED SEVERAL IMPORTANT IMMUNE
RESPONSES
GENERATED BY THE VACCINE AGAINST SARS-COV-2 AFTER A SINGLE
INJECTION
    * HEAT BIOLOGICS - COVID-19 VACCINE INDUCED EXPANSION OF
"KILLER"
CD8+ T CELLS THAT DESTROY VIRUS INFECTED CELLS
    * HEAT BIOLOGICS - COVID-19 VACCINE INDUCED EXPANSION OF
"HELPER"
CD4+ T CELLS THAT ASSIST IN PRODUCING HIGHLY SPECIFIC ANTIBODIES
    * HEAT BIOLOGICS INC - BELIEVE VACCINE HAS POTENTIAL TO BE
USED AS
EITHER A STANDALONE VACCINE, OR IN COMBINATION WITH OTHER
APPROACHES

Source text: https://bit.ly/3iIuaVr
Further company coverage:  HTBX.O 

 ((Reuters.Briefs@thomsonreuters.com;))